Dowling & Yahnke’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $21.6M | Sell |
42,702
-45
| -0.1% | -$23.7K | 1% | 21 |
|
|
2022
Q2 | $22M | Buy |
42,747
+404
| +1% | +$203K | 1.03% | 20 |
|
|
2022
Q1 | $21.6M | Sell |
42,343
-67
| -0.2% | -$32.3K | 0.94% | 24 |
|
|
2021
Q4 | $21.3M | Sell |
42,410
-424
| -1% | -$192K | 1.02% | 22 |
|
|
2021
Q3 | $16.7M | Sell |
42,834
-373
| -0.9% | -$154K | 0.93% | 25 |
|
|
2021
Q2 | $17.3M | Sell |
43,207
-194
| -0.4% | -$77.4K | 0.99% | 23 |
|
|
2021
Q1 | $16.1M | Sell |
43,401
-221
| -0.5% | -$76.6K | 1.1% | 16 |
|
|
2020
Q4 | $15.3M | Sell |
43,622
-540
| -1% | -$181K | 1.09% | 21 |
|
|
2020
Q3 | $13.8M | Sell |
44,162
-1,159
| -3% | -$356K | 1.1% | 19 |
|
|
2020
Q2 | $13.4M | Sell |
45,321
-1,267
| -3% | -$363K | 1.12% | 16 |
|
|
2020
Q1 | $11.6M | Sell |
46,588
-1,881
| -4% | -$518K | 1.12% | 18 |
|
|
2019
Q4 | $14.2M | Sell |
48,469
-559
| -1% | -$146K | 1.09% | 18 |
|
|
2019
Q3 | $10.7M | Sell |
49,028
-659
| -1% | -$159K | 0.88% | 25 |
|
|
2019
Q2 | $12.1M | Buy |
49,687
+8
| +0% | +$1.92K | 1% | 21 |
|
|
2019
Q1 | $12.3M | Sell |
49,679
-768
| -2% | -$196K | 1.18% | 16 |
|
|
2018
Q4 | $14.2M | Buy |
50,447
+661
| +1% | +$175K | 1.47% | 9 |
|
|
2018
Q3 | $13.2M | Sell |
49,786
-662
| -1% | -$172K | 1.16% | 14 |
|
|
2018
Q2 | $12.4M | Sell |
50,448
-660
| -1% | -$158K | 1.15% | 14 |
|
|
2018
Q1 | $10.9M | Sell |
51,108
-1,563
| -3% | -$357K | 1.02% | 17 |
|
|
2017
Q4 | $11.6M | Sell |
52,671
-1,142
| -2% | -$242K | 1.05% | 15 |
|
|
2017
Q3 | $10.5M | Sell |
53,813
-636
| -1% | -$123K | 1.07% | 14 |
|
|
2017
Q2 | $10.1M | Sell |
54,449
-1,763
| -3% | -$309K | 1.06% | 16 |
|
|
2017
Q1 | $9.22M | Sell |
56,212
-701
| -1% | -$115K | 0.98% | 20 |
|
|
2016
Q4 | $9.11M | Sell |
56,913
-2,072
| -4% | -$310K | 1.02% | 20 |
|
|
2016
Q3 | $8.26M | Sell |
58,985
-77
| -0.1% | -$10.8K | 0.97% | 21 |
|
|
2016
Q2 | $8.34M | Buy |
59,062
+1,094
| +2% | +$146K | 1% | 21 |
|
|
2016
Q1 | $7.47M | Buy |
57,968
+878
| +2% | +$104K | 0.92% | 24 |
|
|
2015
Q4 | $6.72M | Sell |
57,090
-1,570
| -3% | -$183K | 0.84% | 26 |
|
|
2015
Q3 | $6.8M | Buy |
58,660
+593
| +1% | +$71K | 0.93% | 22 |
|
|
2015
Q2 | $7.08M | Sell |
58,067
-408
| -0.7% | -$48.3K | 0.89% | 19 |
|
|
2015
Q1 | $6.92M | Sell |
58,475
-519
| -0.9% | -$57.6K | 0.86% | 23 |
|
|
2014
Q4 | $5.96M | Sell |
58,994
-1,361
| -2% | -$129K | 0.74% | 37 |
|
|
2014
Q3 | $5.21M | Buy |
60,355
+133
| +0.2% | +$11.2K | 0.69% | 42 |
|
|
2014
Q2 | $4.92M | Sell |
60,222
-1,316
| -2% | -$104K | 0.64% | 49 |
|
|
2014
Q1 | $5.05M | Buy |
61,538
+555
| +0.9% | +$41.8K | 0.66% | 42 |
|
|
2013
Q4 | $4.59M | Buy |
60,983
+2,107
| +4% | +$151K | 0.65% | 51 |
|
|
2013
Q3 | $4.22M | Buy |
58,876
+40
| +0.1% | +$2.86K | 0.66% | 49 |
|
|
2013
Q2 | $3.85M | Buy |
+58,836
| New | +$3.66M | 0.64% | 53 |
|
Other funds holding UNH
Dowling & Yahnke's UNH Position: Q3 2022 in Review
Dowling & Yahnke reduced its UnitedHealth (UNH) stake by 0.11% in Q3 2022, selling an estimated $23.7K and leaving 42,702 shares worth $21.6M. The position accounts for 1% of the portfolio, ranked #21.
Dowling & Yahnke first reported a position in UNH in Q2 2013 and has held it in 38 quarters since. The position peaked at $22M in Q2 2022. 2,994 funds tracked by Wall St. Rank hold UNH as of Q3 2022.
- Dowling & Yahnke held 42,702 shares of UnitedHealth worth $21.6M as of Q3 2022.
- Dowling & Yahnke sold 45 UnitedHealth shares in Q3 2022, an estimated $23.7K.
- UnitedHealth made up 1% of Dowling & Yahnke's portfolio in Q3 2022, its #21 holding.
- Dowling & Yahnke first reported a position in UnitedHealth in Q2 2013 and has held it in 38 quarters since.
- Dowling & Yahnke's UnitedHealth position peaked at $22M in Q2 2022.
- 2,994 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.